This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Lexicon Pharmaceuticals Inc (LXRX)

NASDAQ: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) -104.13M -110.21M -116.22M -101.78M
Operating Gains/Losses 0.00 0.00 0.00 -141.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 588.00K -1.03M 394.00K 488.00K
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 3.12M -995.00K 10.36M -5.24M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital -447.00K -197.00K 319.00K -946.00K
Other Non-Cash Items 5.21M 16.38M 13.18M 9.19M
Net Cash From Continuing Operations -91.08M -94.46M -87.94M -82.37M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -91.08M -94.46M -87.94M -82.37M
Sale of Property, Plant & Equipment 130.00K 85.00K 2.62M 64.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 212.62M 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -1.72M -492.00K -1.21M -1.13M
Acquisitions 0.00 0.00 0.00 -5.56M
Purchases of Short-Term Investments -111.49M 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 176.63M 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 99.54M -97.81M 69.96M -113.84M
Issuance of Debt 0.00 0.00 0.00 11.38M
Cash Used for Financing Activities
Issuance of Capital Stock 1.08M 38.11M 160.78M 181.50M
Repayment of Long-Term Debt -1.57M -1.44M -3.59M -49.86M
Repurchase of Capital Stock -873.00K -285.00K -108.00K -149.00K
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -26.00K 0.00 0.00 0.00
Net Cash From Financing Activities -1.39M 36.38M 157.08M 142.87M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 7.08M -155.89M 139.10M -53.35M
LXRX News

LXRX Lexicon Pharmaceuticals Inc

Analysts Ratings for LXRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 4
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
GET LXRX ANALYST REPORT

Brokerage Partners

LXRX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs